Ingevity Q3 net sales miss estimates

Ingevity

05/11/2025 22:46

Overview

Ingevity Q3 net sales from continuing operations flat yr/yr, missing analyst expectations

Company announces sale of Industrial Specialties and North Charleston refinery for $110 mln

Outlook

Ingevity revises 2025 guidance: net sales between $1.25 bln and $1.35 bln

Company expects 2025 adjusted EBITDA between $390 mln and $405 mln

Challenges in Advanced Polymer Technologies delay industrial demand recovery

Result Drivers

PERFORMANCE MATERIALS - Sales increased 3% driven by improved global auto production

ADVANCED POLYMER TECHNOLOGIES - Sales declined due to tariff impacts and increased competition in China

PERFORMANCE CHEMICALS - Record North America pavement sales contributed to segment growth

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Sales
Miss
$333.10 mln
$360.43 mln (3 Analysts)
Q3 EPS
$1.18
Q3 Net Income
$43.50 mln
Q3 Gross Profit
$133.90 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the diversified chemicals peer group is "buy"

Wall Street's median 12-month price target for Ingevity Corp is $69.50, about 24.3% above its November 4 closing price of $52.58

The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 9 three months ago

Press Release: ID:nBw3mLZHma

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)